Enterocolitis clinical trials
The registry lists 21 studies for Enterocolitis across more than 10 countries. 3 are recruiting or about to start. 5 of them are mainly about Enterocolitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-09. Counting its 2 narrower conditions too, such as Enterocolitis, Necrotizing: 285 studies, 52 open.
Get an email when these change. Save the Enterocolitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Michael E. DeBakey VA Medical Center (2) · Chang Gung Memorial Hospital (2) · Yale University (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University of Michigan (1) · Alder Hey Children's NHS Foundation Trust (1) · Dina Kao (1) · Brigham and Women's Hospital (1)
What is being tested here
Drugs under test in Enterocolitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Jan 2027A Study of SER-155 to Treat Diarrhea in People on Immunotherapy · Memorial Sloan Kettering Cancer Center
Who these studies take
Of the 2 Enterocolitis studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 1 (50%) |
| 18 | 1 (50%) | 1 (50%) |
| 30 | 1 (50%) | 1 (50%) |
| 40 | 1 (50%) | 1 (50%) |
| 50 | 1 (50%) | 1 (50%) |
| 65 | 1 (50%) | 1 (50%) |
| 75 | 1 (50%) | 1 (50%) |
| 85 | 1 (50%) | 1 (50%) |
Across all 21 studies, recruiting or not: 62% stop at 75 or younger and 62% at 65; 62% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- A Study of SER-155 to Treat Diarrhea in People on ImmunotherapyRecruitingNCT06801067Phase 11 country
- Babies With Enterocolitis - A Study of Faecal Calprotectin in Hirschsprung Disease (The BEACH Study)Not yet recruitingNCT06592534
- A Multicentre French Prospective Study of Children With Food Protein Induced Enterocolitis Syndrome in Its Acute FormRecruitingNCT05528900Not applicable1 country
- Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 MutationsActive, not recruitingNCT04641442Phase 27 countries
- Use of Faecal Calprotectin to Predict Enteropathy of the Preterm NeonatesCompletedNCT02010268Not applicable1 country
- Probiotics and Post-Pullthrough Hirschsprung's Disease-Associated EnterocolitisCompletedNCT07098494Not applicable1 country
- Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff InfectionCompletedNCT03353506Phase 21 country
- FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. DiffCompletedNCT02254811Phase 2/31 country
- Impact of Oral Antibiotic Treatment on C. DifficileCompletedNCT02057198Phase 41 country
- Addition of Lactobacillus to Metronidazole in Treatment of CDADWithdrawnNCT00304863Phase 41 country
- Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung DiseaseStatus unknownNCT021936851 country
- Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)CompletedNCT00630838Phase 21 country
- Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared SpectroscopyStatus unknownNCT02534090
- Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal HealingCompletedNCT01174186Phase 41 country
- Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile InfectionsWithdrawnNCT01077245Phase 2
- A Trial on Probiotics in Preventing Hirschsprung's Disease Associated EntercolitisCompletedNCT01934959Early Phase 1
- The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella EnterocolitisStatus unknownNCT01278017Phase 41 country
- Fecal Bacterial Flora in Clostridium Difficile-Associated DiarrheaCompletedNCT003048761 country
- Role of Epidermal Growth Factor (EGF) in Development of Necrotizing EnterocolitisCompletedNCT000594491 country
- Effect of Probiotics (Bio-Three) in Children's EnterocolitisCompletedNCT00463190Phase 41 country
- Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human InfantsCompletedNCT00252681Not applicable1 country